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Summary
The occurrence of a range of recalcitrant organic
micropollutants in our aquatic environment has led
to the development of various tertiary wastewater
treatment methods. In this study, biogenic manganese
oxides (Bio-MnOx), biogenic silver nanoparticles
(Bio-Ag0) and ionic silver were used for the oxidative
removal of the frequently encountered drug diclofenac
and its dechlorinated form, 2-anilinophenylacetate
(APA). Diclofenac was rapidly degraded during
ongoing manganese oxidation by Pseudomonas
putida MnB6. Furthermore, whereas preoxidized Bio-
MnOx, Bio-Ag0 and Ag+ separately did not show any
removal capacity for diclofenac, an enhanced removal
occurred when Bio-MnOx and silver species were
combined. Similar results were obtained for APA.
Finally, a slow removal of diclofenac but more rapid
APA degradation was observed when silver was added
to manganese-free P. putida biomass. Combining
these results, three mechanisms of diclofenac and
APAremoval could be distinguished: (i) a co-metabolic
removal during active Mn2+ oxidation by P. putida; (ii) a
synergistic interaction between preoxidized Bio-MnOx
and silver species; and (iii) a (bio)chemical process by
biomass enriched with silver catalysts. This paper
demonstrates the use of P. putida for water treatment
purposes and is the first report of the application of
silver combined with biogenic manganese for the
removal of organic water contaminants.
Introduction
Since the discovery of a range of pharmaceuticals and
personal care products in surface water, groundwater
and even drinking water (Ternes, 1998; Heberer, 2002;
Mompelat et al., 2009), tertiary treatment methods were
developed to remove micropollutants after conventional
wastewater treatment. Physicochemical techniques for
the removal of micropollutants are mostly based upon
filtration and oxidative processes (Ikehata et al., 2006)
but may have specific disadvantages, such as high costs
(Johnson and Sumpter, 2001), the formation of toxic
by-products (Guzzella et al., 2002; Richardson et al.,
2007) and inefficiency against certain compounds (Ternes
et al., 2003). Biogenic metals have shown to be useful
catalysts for the removal of recalcitrant organic com-
pounds. Biogenic palladium nanoparticles are efficient
catalysts for the reductive transformation of halogenated
organics, such as diatrizoate (Hennebel et al., 2010; De
Gusseme et al., 2011a) and diclofenac (De Gusseme
et al., 2012). However, these reductive treatments are
generally limited to a dehalogenation step, upon which
other treatments are required to remove the formed reac-
tion products. As such, the end-product of a reduction of
diclofenac with biogenic palladium is its dechlorinated
form 2-anilinophenylacetate (APA) (De Corte et al., 2011;
De Gusseme et al., 2012). Conversely, oxidative biological
techniques of micropollutant removal are under investiga-
tion. For example, biogenic manganese(III,IV) oxides (Bio-
MnOx) can be successfully used for the removal of a range
of pharmaceuticals (Forrez et al., 2010; 2011). The oxida-
tive power of manganese oxide compares with that of
oxygen gas (Thauer et al., 1977). In addition, the effi-
ciency of micropollutant removal is further improved by the
presence of manganese-oxidizing bacterial biomass: a
continuous cyclic reoxidation of manganese can theoreti-
cally result in a sustained removal of micropollutants (de
Rudder et al., 2004; De Schamphelaire et al., 2007) and
oxidation products might be further degraded by the bac-
terial metabolism, increasing the driving force of the initial
reaction. Finally, evidence exists that during the oxidation
of Mn2+ to Mn4+ by bacteria such as Pseudomonas putida
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and Bacillus sp. SG-1, ligand-bound Mn3+ intermediates
are produced that might sensitively increase the oxidative
power of a manganese-bacteria mixture (Kostka et al.,
1995; Parker et al., 2004; Murray and Tebo, 2006).
In water treatment, the disinfecting activity of both
chemically and biologically produced silver nanoparticles
(Bio-Ag0) has been shown valuable for the inactivation
of bacteria and viruses (Jain and Pradeep, 2005; De
Gusseme et al., 2011b). Additionally, silver nanoparticles
can be used as catalysts in a range of organic redox
reactions (Jiang et al., 2005; Xu et al., 2006). Whereas
silver compounds are generally weak redox catalysts,
studies have demonstrated a sensitive increase in activity
for composite metal catalysts. For example, Haruta and
Sano (1983) demonstrated a higher activity of Ag–Co and
Ag–Mn composite oxides, in comparison with the single-
component oxides, for the oxidation of hydrogen gas to
H2O and carbon monoxide to CO2. Comparable results
were obtained for the catalytic oxidation of volatile organic
compounds, such as acetone and pyridine (Luo et al.,
1998).
This study has explored the applicability of Bio-MnOx
and silver species for the oxidative removal of micropollut-
ants during water treatment, using the chlorinated pharma-
ceutical compound diclofenac as a model pollutant. The
main objectives were (i) to evaluate the influence of
the manganese-oxidizing metabolism of P. putida on the
removal of diclofenac with Bio-MnOx; (ii) to determine the
effects of an enrichment of manganese oxides with silver
species on the degradation of diclofenac; and (iii) to assess
the degradation of 2-anilinophenylacetate, the dechlori-
nated product of diclofenac.
Results
Influence of manganese-oxidizing metabolism on
diclofenac removal
Diclofenac (3 mg l-1) and manganese chloride
(3.28 mg Mn2+ l-1) were added simultaneously to a
P. putida culture. In a parallel setup, diclofenac was added
113 h after the addition of Mn2+, to allow a complete oxi-
dation of manganese by the bacteria prior to the addition
of diclofenac. Diclofenac was readily removed in batches
where manganese was simultaneously oxidized, with a
decrease of 96  2% within 44 h (first-order rate constant
k = 0.065 h-1), while a lower decrease of 13  6% after
75 h (k = 0.0023 h-1) was observed in batches where
manganese was oxidized prior to diclofenac addition
(Fig. 1A). Manganese-free control experiments, in which
an equal amount of bacteria was used, showed a
diclofenac removal of 14  2% after 142 h.
To address the importance of bacterial metabolism
during manganese oxidation and thus diclofenac degra-
dation, control experiments using heat inactivated cul-
tures of P. putida were set up (Fig. 1B). Upon addition
of 3.28 mg Mn2+ l-1 and 3 mg l-1 diclofenac to non-viable
biomass, no formation of biogenic manganese oxides
could be observed and a slight removal of 19  15%
diclofenac was seen after 119 h of incubation. In contrast,
after the addition of equal amounts of manganese and
diclofenac to a viable P. putida culture, repeating the
active manganese oxidation of the previous experiment
shown in Fig. 1A, a faster removal of diclofenac was
observed (97  3% after 119 h, Fig. 1B).
Subsequently, it was tested whether preformed Bio-
MnOx could facilitate the reoxidation of Mn2+ in an
autocatalytic manner, rendering the bacterial manganese-
oxidizing metabolism unnecessary for the ensuing
removal of diclofenac. To this extent, heat inactivation of
preformed Bio-MnOx (3.28 mg Mn l-1) was performed,
after which an additional amount of 1.64 mg Mn2+ l-1 and
3 mg l-1 diclofenac were added. The diclofenac concen-
tration decreased only to a limited extent (29  12% after
119 h), which was in contrast to the diclofenac removal
after addition of equal amounts of Mn2+ and diclofenac to
viable Bio-MnOx. Indeed, the latter amounted to 97%  1
after 119 h (Fig. 1B), which was again comparable to the
Fig. 1. Removal of diclofenac by preformed Bio-MnOx and
by active manganese-oxidizing metabolism of P. putida.
A. During oxidation of 3.28 mg Mn2+ l-1 (‘Pseudomonas + Mn2+’),
after complete oxidation of Mn2+ (‘Pseudomonas + Bio-MnOx’)
and in manganese-free controls (‘Pseudomonas control’).
B. In heat-inactivated P. putida cultures supplied with
3.28 mg Mn2+ l-1 (‘dead Pseudomonas + Mn2+’), in heat-inactivated
Bio-MnOx (3.28 mg Mn l-1) supplied with another 1.64 mg Mn2+ l-1
added (‘dead Bio-MnOx + Mn2+’), and in living controls.
C0 = 3 mg l-1 diclofenac.
Error bars indicate standard deviations of three replicates;
sometimes smaller than symbols.
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diclofenac removal rate during active manganese oxida-
tion obtained in the previous experiments.
Improved diclofenac removal in the presence of silver
To further improve the reactivity of manganese oxides,
the influence of silver species on the degradation of
diclofenac by Bio-MnOx was assessed. When diclofenac
was added to a mixture of preformed Bio-MnOx
(3.28 mg Mn l-1) and either ionic silver or biogenic nano-
particles (Bio-Ag0) (5 mg Ag l-1), removal percentages of
92  3% and 91  5%, respectively, were obtained after
159 h (first-order rate constants k = 0.017 and 0.016 h-1).
Control experiments containing Bio-Ag0, Ag+ (5 mg Ag l-1)
or Bio-MnOx (3.28 mg Mn l-1) separately showed little to
no diclofenac removal (Fig. 2A) (k = 0 h-1, 0.0003 h-1 and
0.0023 h-1 respectively).
At increased biomass and metal concentrations,
diclofenac removal rates were sensitively enhanced
(Fig. 2B). When increasing the concentrations of
biomass, manganese and silver by a factor 2 and 10, a
better removal of 97  0.4% after 76 h and 99  0.4%
after 21 h, respectively, could be obtained. This corre-
sponded with a factor 3.6 and 5.7 increase in the
diclofenac removal rate constants (k = 0.058 h-1 and
0.091 h-1 respectively).
To distinguish degradation processes from sorption,
a respiking experiment was performed for diclofenac
removal by Bio-MnOx (6.55 mg Mn l-1) and Bio-Ag0
(10 mg Ag l-1) (Fig. 3). Diclofenac was removed by
94  1% after 144 h during a first incubation period. After
173 h, the batches were respiked to the initial concentra-
tion of 3 mg l-1 diclofenac. During a second incubation
period, diclofenac was removed at a comparable rate,
with a decrease of 98  0.5% after 141 h. A parallel
control experiment, containing manganese-free P. putida
biomass with Bio-Ag0, showed a diclofenac removal by
41  9% after 144 h during the first incubation and
42  7% after 141 h during the second incubation period.
Removal of APA
To examine the structural importance of the chlorine
moieties in the diclofenac molecule and their contri-
bution to its degradability by manganese and silver
species, degradation experiments were performed
using 2-anilinophenylacetate (APA) (Fig. 4). When
3.28 mg Mn2+ l-1 and 3 mg APA l-1 were added to a viable
P. putida culture, APA was removed by 85  2% after 45 h
during active manganese oxidation, after a lag phase of
23 h in which no visible formation of Bio-MnOx or APA
removal was observed. In contrast, control experiments
using manganese-free biomass showed no APA removal.
In the presence of preoxidized Bio-MnOx (3.28 mg Mn l-1)
and Bio-Ag0 (5 mg Ag l-1), APA was removed by 82  8%
after 44 h. Surprisingly, a control experiment containing a
Fig. 2. Removal of diclofenac by combined manganese and silver
species.
A. By Bio-MnOx (3.28 mg Mn l-1) combined with Bio-Ag0 or Ag+
(5 mg Ag l-1), and by Bio-Ag0, Ag+ and Bio-MnOx as separate
controls.
B. Diclofenac removal at elevated metal concentrations:
3.28 mg Mn l-1 as Bio- MnOx with 5 mg l-1 silver as Bio-Ag0,
and twofold and 10-fold increases. C0 = 3 mg l-1 diclofenac.
Error bars indicate standard deviations of three replicates;
sometimes smaller than symbols.
Fig. 3. Removal of diclofenac by Bio-Ag0 (10 mg Ag l-1) combined
with P. putida biomass and with preoxidized Bio-MnOx
(6.55 mg Mn l-1). C0 = 3 mg l-1 diclofenac. The arrow marks a
respiking of diclofenac to 3 mg l-1 at time t = 173 h. Error bars
indicate standard deviations of three replicates; sometimes smaller
than symbols.
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mixture of Bio-Ag0 (5 mg Ag l-1) and a manganese-free
P. putida culture showed an even faster removal, with a
decrease of APA concentration by 90  2% after 19 h.
Discussion
Traditional wastewater treatment is focused on the
removal of the organic load (chemical oxygen demand,
COD) and nutrient concentrations before discharge in
natural aquatic systems. However, with continuously
increasing global water demands, the need to develop
techniques for wastewater reuse arises. Of specific
concern for the reuse of water is the presence of persis-
tent organic compounds, such as certain pharmaceuti-
cals, pesticides and industrial chemicals. This research
has elaborated on the use of biogenic manganese oxides
as novel agents for the removal of micropollutants, in
continuation of the research of Sabirova and colleagues
(2008) and Forrez and colleagues (2010; 2011). More-
over, this study used for the first time silver as a catalyst,
combined with manganese oxides, for the removal of
micropollutants.
Removal of diclofenac during active
manganese oxidation
Almost no removal of diclofenac in the presence of pre-
formed Bio-MnOx was observed. In contrast, during
active Mn2+ oxidation by P. putida, diclofenac was readily
removed, with almost a 30-fold increase of the first-order
rate constant (Fig. 1). This suggests a participating role
of the manganese-oxidizing metabolism of the bacteria
in the removal of diclofenac, especially since heat-
inactivated cultures showed no considerable diclofenac
removal. Although it is known that the autocatalytic oxida-
tion of Mn2+ may occur on the surface of preformed man-
ganese oxides (Murray, 1975), these results show that
possible intermediates during the autocatalytic oxidation
of MnO2 do not contribute to the degradation of
diclofenac, but that, in contrast, the metabolic activity of
the biomass is the most significant factor herein. The
oxidation of manganese by P. putida likely involves a mul-
ticopper enzyme, which oxidizes Mn2+ to a ligand-bound
Mn3+ intermediate (Parker et al., 2004; Tebo et al., 2004;
Webb et al., 2005). This highly reactive Mn3+ intermediate
is then thought to be further oxidized to Mn(IV) oxide by
putative enzymes in the extracellular mucous layer of the
bacteria (De Vrind et al., 2003). A three-step model of the
oxidizing activity of Bio-MnOx can be proposed (Fig. 5): (i)
Mn2+ is oxidized to a ligand-bound Mn3+ intermediate,
presumably by a multicopper enzyme of P. putida; (ii) this
Mn3+ intermediate can either be further oxidized to Mn(IV)
oxide, plausibly by enzymes on the cell surface; or (iii) the
reactive Mn3+ intermediate can oxidize other compounds,
such as micropollutants, upon which Mn2+ is formed
again. As such, the degradation of diclofenac can be
considered a co-metabolic process during the oxidation of
manganese. The model presented here is in concordance
with Forrez and colleagues (2010), who observed that
diclofenac removal by Bio-MnOx was inhibited when
P. putida was treated with sodium azide, a biostatic agent.
Further study should focus on the technical challenge of
verifying this model by demonstrating the formation of
unstable Mn3+ intermediates and correlating their pres-
ence with the oxidation of diclofenac. Moreover, research
on mutant strains should allow to identify the different
Fig. 4. Removal of APA by P. putida during active oxidation of Mn2+
(3.28 mg l-1); by preoxidized Bio-MnOx (3.28 mg Mn l-1) combined
with Bio-Ag0 (5 mg Ag l-1); and by manganese-free controls.
C0 = 3 mg APA l-1. Error bars indicate standard deviations of three
replicates; sometimes smaller than symbols.
Fig. 5. Proposed model of the oxidation
of Mn2+ by P. putida and the co-metabolic
degradation of micropollutants such as
diclofenac: (1) oxidation of Mn2+ to a
ligand-bound Mn3+ intermediate (after
Parker et al., 2004; Tebo et al., 2004; Webb
et al., 2005); (2) oxidation of Mn3+ to MnO2
(after De Vrind et al., 2003); (3) reduction of
Mn3+ to Mn2+ with concomitant oxidation of
the micropollutant.
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P. putida enzymes involved in the oxidation of manganese
and clarify the mechanism of diclofenac oxidation during
this process.
Removal of diclofenac by the activity of silver species
To increase the overall reactivity, Ag+ and Bio-Ag0 were
added to Bio-MnOx, upon which diclofenac was rapidly
removed. A respiking experiment (Fig. 3) clearly refuted
the possibility of sorption as the prime mechanism of
diclofenac removal by this silver – Bio-MnOx mixture,
suggesting a catalytic nature of the process. Silver and
biogenic manganese oxides cooperate in a synergistic
manner, increasing the diclofenac removal rate to a higher
level than would be expected from combining the removal
rates of both separately: Ag+, Bio-Ag0 and Bio-MnOx
alone showed little to no diclofenac removal (Fig. 2). Like-
wise, Imamura and colleagues (1988) observed similar
synergistic interactions between manganese and silver
oxides for the oxidation of gaseous carbon compounds.
A surprising increase of the diclofenac removal rate
was already observed when Bio-Ag0 was combined
with manganese-free biomass (Fig. 3). One possible
explanation could involve the formation of reactive oxygen
species (ROS), such as hydroxyl radicals, superoxide and
peroxide, since both ionic silver (Matsumura et al., 2003;
Park et al., 2009) and silver nanoparticles (Su et al., 2009;
Sintubin et al., 2011) have been shown to interact with
the cell wall and intracellular respiratory enzymes of
bacteria, thereby creating ROS. Given the susceptibility
of diclofenac towards oxidation by ROS (Hofmann et al.,
2007; Sein et al., 2008), it is considered plausible that the
observed removal of diclofenac in the presence of Bio-Ag0
in a P. putida culture occurs through this reaction.
In this study, no definite conclusions could be made
regarding the mechanism of the observed Bio-MnOx –
silver interaction during the degradation of diclofenac.
Yet, the results hitherto suggest a twofold mode of action:
(i) silver species (Ag+ and Bio-Ag0) interact with P. putida
biomass in such a way that diclofenac is slowly removed;
and (ii) silver species enhance the reactivity of Bio-MnOx,
in such a way that diclofenac is more rapidly removed. It
is suggested that further research should attempt to dem-
onstrate an increased amount of ROS when the bacterial
cells are triggered by silver and the subsequent effects
on micropollutants such as diclofenac. Likewise, the
mechanism of the observed catalytic manganese – silver
synergy should be addressed. Furthermore, given the
antibacterial activity of silver (Morones et al., 2005;
Bjarnsholt et al., 2007; Yoon et al., 2007), careful study
should determine whether silver may be added to active
P. putida biomass at concentrations sufficiently low not to
inhibit the oxidation of manganese and the associated
diclofenac removal, while still allowing the catalytic
silver – Bio-MnOx interaction to further enhance diclofenac
removal rates.
Differences in reactivity between diclofenac and APA
The end-product of a reductive treatment of diclofenac
with, for example, palladium or palladium – gold catalysts
is 2-anilinophenylacetate (APA) (De Corte et al., 2011;
De Gusseme et al., 2012). In order to explore the use of
manganese and silver species to complement such
reductive treatments, additional removal experiments
were conducted with APA. During active bacterial oxida-
tion of manganese, APA was rapidly removed after a
23-hour lag phase, in which no manganese oxide forma-
tion and APA removal occurred (Fig. 4). After this delayed
onset of manganese oxidation, the APA removal rate
was comparable to that of diclofenac under equal cir-
cumstances. Remarkably, when silver was added to a
manganese-free P. putida culture, a faster APA removal
was observed than when combined with Bio-MnOx. Thus,
it is concluded that silver acts as an efficient catalyst for
the removal of APA in the presence of P. putida biomass
and that manganese is not required in this reaction.
A comparison of the degradation kinetics of diclofenac
with those of APA might provide more insight in the struc-
tural importance of the chlorine moieties of diclofenac and
in the mechanism by which it is transformed. The main
bacterial degradation pathway of diclofenac is an oxida-
tion to 5-hydroxydiclofenac, followed by (aut)oxidation to
diclofenac-2,5-iminoquinone (Gröning et al., 2007). Like-
wise, these two compounds were the only metabolites
detected for diclofenac degradation by Bio-MnOx (Forrez
et al., 2010), although they only accounted for 5–10% of
the total diclofenac removal. In this study, both diclofenac
and APA were removed at comparable rates during the
ongoing oxidation of manganese by P. putida. Therefore,
it is concluded that the chlorine moieties of diclofenac do
not affect its principal degradation pathway, which is likely
to involve a hydroxylation of the ring structure. When
added to a combination of Bio-MnOx and Bio-Ag0, APA
was removed at a lower rate than in a manganese-free
bacterial culture containing only Bio-Ag0 (Fig. 4), suggest-
ing that manganese oxides are not required for the deg-
radation of APA by Bio-Ag0 and even interfere with it. On
the contrary, an enhanced removal rate was observed for
diclofenac in the presence of both manganese oxides and
silver, compared with silver in a manganese-free bacterial
culture (Fig. 3). It is therefore concluded that the principal
degradation mechanism of diclofenac by manganese and
silver might differ from that of APA and that the chlorine
moieties of diclofenac counter its degradability by silver in
manganese-free biomass. Possibly, APA is, more than
diclofenac, sensitive to degradation by the ROS that are
produced extra- and intracellularly in the presence of
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silver ions. This might explain the higher APA removal rate
in the absence of Bio-MnOx, since deposits of manga-
nese oxides on the bacterial cell wall are expected to
obstruct cross-membrane transport. Diclofenac, on the
other hand, is primarily degraded as the result of a hith-
erto unspecified synergistic interaction between manga-
nese oxides and silver.
Conclusive remarks
This research has shown that biogenic manganese and
silver species can be used as novel agents for the oxida-
tive and catalytic removal of micropollutants. Further
research should focus on determining the range of differ-
ent micropollutants that can be removed by these agents
and optimizing the removal conditions, as well as unrav-
elling the reaction mechanisms and identifying the formed
metabolites. Additionally, careful study should allow
assessing and improving the economic feasibility of water
treatment with Bio-MnOx and Bio-Ag0, in order to trans-
form these promising, innovative materials into an effec-
tive solution to the problem of recalcitrant organic water
pollution.
Experimental procedures
Bacterial growth conditions
Pure cultures of P. putida MnB6 (BCCM/LMG 2322) were
grown on a platform shaker (111 r.p.m.) at 28°C under
aerobic conditions, in 100 ml or 250 ml Erlenmeyer flasks.
The growth medium was prepared according to Boogerd and
de Vrind (1987). The cultures were incubated until an optical
density (610 nm) of 1.0  0.3 was reached, measured after
syringe-and-needle homogenization.
Diclofenac and APA removal during active
manganese oxidation
Pseudomonas putida cultures with optical density (610 nm)
of 1.0  0.3 were enriched with manganese chloride
(3.28 mg Mn2+ l-1) from a stock solution of 500 mg MnCl2 l-1
(218 mg Mn2+ l-1) that was previously filter sterilized (0.22 mm,
Millipore) and stored at 4°C. Diclofenac was added at the
desired time from a cool-stored stock solution in distilled
water. Likewise, APA was added from a cool-stored stock
solution in 70% ethanol. Experiments were incubated in
100 ml or 250 ml Erlenmeyer flasks, leaving a headspace
volume equal to or greater than the volume of the culture
liquid, to ensure aerobic conditions. For heat-inactivation
experiments, Erlenmeyer flasks containing P. putida biomass
or preoxidized Bio-MnOx were placed in hot water for
10 min at 60°C. All experiments were performed in triplicate.
Between sampling points, batches were stored on a platform
shaker (111 r.p.m.) at 28°C. Manganese-free P. putida con-
trols were treated identically.
Diclofenac and APA removal by preformed Bio-MnOx
and silver species
Preoxidized Bio-MnOx was produced according to Forrez
and colleagues (2010). In brief, P. putida cultures were grown
to an optical density (610 nm) of 1.0  0.3 and enriched with
manganese chloride (3.28 mg Mn2+ l-1) as described above,
and stored on a platform shaker at 28°C during 24 h for a
complete oxidation of the Mn2+. The Bio-MnOx were then
centrifuged (10 min at 7500 g) and washed twice (10 min at
10 000 g) with phosphate buffer (10 mM KH2PO4/K2HPO4,
pH 7–8). The pellets were resuspended at the desired con-
centration in a test solution containing 0.6 g NaCl l-1 and
10 mM phosphate buffer (pH 7). Manganese-free control cul-
tures were treated identically.
The production of Bio-Ag0 was performed following the
protocol of Sintubin and colleagues (2009): Lactobacillus
fermentum G2/10 was grown in Man-Rogosa-Sharpe (MRS)
broth (Oxoid) at 28°C on a platform shaker (111 r.p.m.) for
48 h. The biomass was harvested and washed twice with
Milli-Q water by means of centrifugation (5 min at 10 000 g).
After determination of the cell dry weight (CDW ª cell wet
weight ¥ 0.23), the biomass was resuspended in Milli-Q
water to a concentration of 4.6 g CDW l-1 and alkalified with
0.025 M NaOH. Silver (1 g l-1) was added in the diamine-
complexed form, from a stock solution of silver nitrate that
was dosed with ammonium hydroxide until all formed silver
precipitates were redissolved. After 24h of incubation (28°C,
111 r.p.m.), the biomass and the formed Bio-Ag0 were
washed thrice (15 min, 10 000 g) with Milli-Q water. The con-
centration of silver, present on the biomass as Bio-Ag0, was
determined by atomic absorption spectroscopy (AA-6300
atomic absorption spectroscope, Shimadzu) after addition of
2 ml HNO3 (65%) and 2 ml H2O2 (30%) to a 2 ml Bio-Ag0
sample and subsequent heating until the solution was clear.
According to the experimental setup, Bio-Ag0 and Ag+,
from a freshly made stock solution of AgNO3 in Milli-Q water,
were added to the Bio-MnOx solution or to Milli-Q water
in 100 ml Erlenmeyer flasks. After addition of diclofenac or
APA (3 mg l-1), batches were stored on a platform shaker
(111 r.p.m.) at 28°C between sampling points. All experiments
were performed in triplicate.
Analytical procedures
Samples for diclofenac and APA measurements were filtered
with regenerated cellulose filters (RC, 0.20 mm, Phenex) or
polyvinylidene fluoride filters (PVDF, 0.22 mm, Millipore),
which both tested negative for sorption of diclofenac and APA
(data not shown). Prior to analysis, the samples were stored
in glass vials at 4°C. Measurements were made using a
Dionex P580 HPLC system with a TCC-100 column oven and
a diode array detector (UVD340U) and processing was done
using Chromeleon 6.80 software. A Genesis C18 column
(150 ¥ 4.6 mm, 4 mm, Alltech) with a guard column was used
for separation. The injection volume was 50 ml. The separa-
tion method was modified from Forrez and colleagues (2010):
at a temperature of 40°C and a flow rate of 1 ml min-1, the
elution was isocratic with 80% HPLC grade methanol and
20% of a solution of 0.1% formic acid in Milli-Q water.
Diclofenac was detected by absorbance at a wavelength of
203 nm, at a retention time of 4 min. APA was analysed by
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HPLC as described for diclofenac. The absorbance was mea-
sured at a wavelength of 275 nm and APA appeared at a
retention time of 3 min. Standards ranging from 0 to 5 mg l-1
were prepared for calibration. The limit of detection (LOD),
i.e. the lowest non-zero point in the calibration series, was
100 mg l-1.
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